These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2569825)

  • 21. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension.
    Levy D; Walmsley P; Levenstein M
    Am Heart J; 1996 May; 131(5):966-73. PubMed ID: 8615318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antihypertensive therapy and lipid metabolism].
    Krone W; Müller-Wieland D; Greten H
    Klin Wochenschr; 1984 Mar; 62(5):193-202. PubMed ID: 6143851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS; Hirokawa WT
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
    Rabkin SW; Huff MW; Newman C; Sim D; Carruthers SG
    Hypertension; 1994 Aug; 24(2):241-8. PubMed ID: 8039850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of doxazosin therapy on risk of coronary heart disease.
    Hansson L
    Am Heart J; 1988 Dec; 116(6 Pt 2):1832-7. PubMed ID: 2904759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension.
    Giorgi G; Legramante JM; Fioravanti G; Paies G; Legramante A
    Am Heart J; 1988 Dec; 116(6 Pt 2):1801-5. PubMed ID: 2904754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT
    Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antihypertensive agents on lipid metabolism.
    Cutler R
    Am J Cardiol; 1983 Feb; 51(4):628-31. PubMed ID: 6131603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters.
    Kowala MC; Nunnari JJ; Durham SK; Nicolosi RJ
    Atherosclerosis; 1991 Nov; 91(1-2):35-49. PubMed ID: 1687433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxazosin effects on insulin and glucose in hypertensive patients. The Finnish Multicenter Study Group.
    Lehtonen A
    Am Heart J; 1991 Apr; 121(4 Pt 2):1307-11. PubMed ID: 1826187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension.
    Davey MJ
    Am J Med; 1989 Aug; 87(2A):36S-44S. PubMed ID: 2569823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.
    Ames RP
    Drugs; 1986 Oct; 32(4):335-57. PubMed ID: 2877846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of doxazosin and other antihypertensives on serum lipid levels and lipoprotein lipase in the C57BR/cdJ mouse.
    Krupp MN; Hoover KW; Valentine JJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S11-8; discussion S18-9. PubMed ID: 2471010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of doxazosin, an alpha 1-blocker, on serum lipids in hypertensive patients.
    Ishimitsu T; Yagi S; Sugishita Y; Fujimura A; Ebihara A; Sakamaki T; Murata K; Saito A
    Hypertens Res; 1996 Mar; 19(1):43-9. PubMed ID: 8829823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic changes during antihypertensive therapies.
    Krone W; Nägele H
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
    Leren P
    Am J Med; 1987 Jan; 82(1A):31-5. PubMed ID: 2879461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of doxazosin on lipid transport in rats and hamsters.
    Ontko JA; Woodside WF
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S31-6; discussions 36-7. PubMed ID: 2471013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
    Jones DW; Sands CD
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):431-7. PubMed ID: 7504134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of doxazosin on plasma lipids and atherogenesis: a preliminary report.
    Kowala MC; Nicolosi RJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S45-9; discussion S49. PubMed ID: 2471015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.